RxRxBriefing
Pharma

Eli Lilly LLY

ELI LILLY & CoPharmaceutical PreparationsIN

Pipeline — registered trials by phase

A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes
— · Diabetes Type 2, Diabetes Mellitus, Glucose Metabolism Disorders · Completed · est. 2024-07-01
Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
— · Diabetic Neuropathies, Diabetes Mellitus, Insulin-Dependent, Diabetes Mellitus, Non-Insulin-Dependent · Completed
A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial
— · Obesity, Heart Failure With Preserved Ejection Fraction (HFpEF) · Completed · est. 2024-07-02
A Phase III Trial For Patients With Metastatic Breast Cancer
— · Breast Cancer, Breast Neoplasms, Cancer of the Breast · Completed · est. 2008-11
Duloxetine Versus Placebo in Chronic Low Back Pain
— · Back Pain Without Radiation · Completed · est. 2007-11
Source: ClinicalTrials.gov (trials where Eli Lilly is lead sponsor; 81 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.

SEC filings — insider trading forms excluded

Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.